IGC Pharma, Inc. Share Price

NYSE: IGCHealthcare

$0.26

-0.01 (3.11%)

BUY SELL

Share Price
Performance Overview
Fundamentals
Return Calculator
Company Info
Popular Stocks
FAQ

Live IGC Pharma, Inc. Share Price Chart

O H L

IGC Pharma, Inc. Performance Overview

Days Range

▼

$0.27Low

$0.27High

Markets Today

Previous Close	$0.27
Open	$0.27
Volume	172,301
Day's Range	$0.27 - $0.27
52W Range	$0.23 - $0.45
Market Cap	$28.12 M

Historical Performance

1M Returns	-6.33
3M Returns	-3.09
6M Returns	-3.30
1Y Returns	-35.32
5Y Returns	-83.45
10Y Returns	-42.09

IGC Pharma, Inc. Fundamentals

Market Cap	$28.12 M
Dividend yield	0.00
PE Ratio	0.00
PEG Ratio	N/A
Revenue	$1.27 M
ROE TTM	N/A
EPS TTM	$-0.08
Quarterly Earnings Growth YOY	N/A
PB Ratio	4.54
EBITDA	$-6.85 M
Profit Margin	-560.27

Market Cap	$28.12 M
Dividend yield	0.00
PE Ratio	0.00
PEG Ratio	N/A
Revenue	$1.27 M
ROE TTM	N/A

EPS TTM	$-0.08
Quarterly Earnings Growth YOY	N/A
PB Ratio	4.54
EBITDA	$-6.85 M
Profit Margin	-560.27

IGC Pharma, Inc. Profit & Loss

	Dec 2024	Mar 2025	Mar 2025	Jun 2025	Mar 2026	Jun 2026
Total Revenue +	$257.00 K	$330.00 K	$330.00 K	$328.00 K	$317.00 K	$265.00 K
Gross Profit +	$104.00 K	$154.00 K	$154.00 K	$154.00 K	$55.00 K	$48.00 K
Operating Income	-$1.88 M	-$1.41 M	-$1.41 M	-$1.91 M	-$2.46 M	-$2.78 M
EBITDA	-$1.72 M	-$1.28 M	-$1.26 M	-$1.76 M	-$2.40 M	-$2.73 M
Interest Expense	$0	$0	$0	$0	$0	$0
Depreciation	$157.00 K	$129.00 K	$154.00 K	$141.00 K	$58.00 K	$56.00 K
Income Before Tax	-$1.83 M	-$1.20 M	-$1.20 M	-$1.60 M	-$2.40 M	-$2.94 M
Income Tax Expense	$0	$0	$0	$0	$0	$0
Net Income +	-$1.83 M	-$1.20 M	-$1.20 M	-$1.60 M	-$2.40 M	-$2.94 M
Net Profit Margin	-711.67%	-362.73%	-363.03%	-487.5%	-757.73%	-1107.92%

IGC Pharma, Inc. Financials Balance Sheet In USD

	Jun 2024	Sep 2024	Dec 2024	Dec 2025	Mar 2026	Jun 2026
Share Capital	$127.35 M	$128.58 M	$129.31 M	$138.01 M	$139.12 M	$142.06 M
Reserve & Surplus	-$119.47 M	-$121.20 M	-$123.05 M	-$130.59 M	-$133.00 M	-$135.93 M
Non-Current Liabilities	$225.00 K	$190.00 K	$162.00 K	$133.00 K	$191.00 K	$149.00 K
Current Liabilities	$2.49 M	$2.80 M	$2.66 M	$2.16 M	$2.87 M	$3.21 M
Total Liabilities	$2.71 M	$2.99 M	$2.82 M	$2.29 M	$3.06 M	$3.36 M
Fixed Assets	$5.31 M	$5.27 M	$5.22 M	$7.24 M	$7.37 M	$7.58 M
Current Assets	$4.41 M	$4.25 M	$3.05 M	$1.79 M	$1.15 M	$1.26 M
Total Assets	$10.59 M	$10.37 M	$9.08 M	$9.71 M	$9.19 M	$9.50 M

IGC Pharma, Inc. Cash Flow

	Dec 2024	Mar 2025	Mar 2025	Jun 2025	Mar 2026	Jun 2026
Net Income	-$1.83 M	-$1.20 M	-$1.20 M	-$1.60 M	-$2.40 M	-$2.94 M
Operating Cash Flow	-$1.32 M	-$730.00 K	-$730.00 K	-$1.41 M	-$1.22 M	-$1.35 M
Investing Cash Flow	-$104.00 K	-$142.00 K	-$142.00 K	$580.00 K	-$170.00 K	-$254.00 K
Financing Cash Flow	$345.00 K	$805.00 K	$805.00 K	$851.00 K	$710.00 K	$1.73 M
Change in Cash	-$1.08 M	-$65.00 K	-$65.00 K	$49.00 K	-$693.00 K	$124.00 K

IGC Pharma, Inc. Return Calculator

The IGC Pharma, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Returns Estimator

Based on past performance of this fund

ENTER AMOUNT

$10,000

Select Duration

5Yrs

1 Yr5 Yrs

If you had invested $10,000 5 years ago, what would its value be today?$1,615

Invested Amount$10,000

Est. Returns$-8,385

Invest in USA Stock Today

About IGC Pharma, Inc.

IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.

FAQs

What is the share price of IGC Pharma, Inc. today?

IGC Pharma, Inc. (IGC) share price as of September 18, 2026 is $0.26. If you are investing from India, you can always check the valuation in the INR before investing.

Can Indian Investors purchase shares of IGC Pharma, Inc.?

Yes, Indian Investors can invest in the IGC Pharma, Inc. (IGC) Share by opening an international trading account with Angel One.

How can I purchase IGC Pharma, Inc. shares in India?

Purchasing IGC Pharma, Inc. (IGC) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying IGC Pharma, Inc. (IGC) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.

Can I buy Fractional shares of IGC Pharma, Inc.?

Yes, you can purchase fractional shares of IGC Pharma, Inc. (IGC) or any other US company shares in Angel One for any dollar amount.

What is the market capitalization value of IGC Pharma, Inc.?

The market capitalization of IGC Pharma, Inc. on September 18, 2026, is $28.12 M.

In which sector IGC Pharma, Inc. belongs?

IGC Pharma, Inc. operates in the Healthcare sector, specifically in the Healthcare industry.

What documents are required to invest in IGC Pharma, Inc. stocks?

In order to invest in IGC Pharma, Inc. (IGC) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.